Vnitr Lek 2017, 63(11):757-769 | DOI: 10.36290/vnl.2017.147

Asthma bronchiale in the context of internal medicine

Milan Teřl
Klinika pneumologie a ftizeologie LF UK a FN v Plzni

The article is supposed to give a modern perspective on etiopatogenesis of asthma and its management. There are accentuated new diagnostics and treatment opportunities as well as coincident areas with others internal fields and pragmatic recommendation for daily clinical practice.

Keywords: allergy; asthma heterogeneity; asthma management; eosinophilia; internal medicine; phenotype-specific therapy; stepwise pharmacotherapy

Received: August 31, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teřl M. Asthma bronchiale in the context of internal medicine. Vnitr Lek. 2017;63(11):757-769. doi: 10.36290/vnl.2017.147.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. GINA (Global Initiative for Asthma). Global Strategy for Asthma Management and Prevention. 2017. Dostupné z WWW: < http://www.ginasthma.org>. [cit. 8/2017].
    2. Teřl M, Čáp P, Dvořáková R et al. Doporučený postup diagnostiky a léčby bronchiálního astmatu. GEUM: Semily 2015. ISBN 978-80-87969-08-3.
    3. Nathan RA, Thompson PJ, Price D et al. Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada and the United States. J Allergy Clin Immunol Pract 2015; 3(5): 734-742.e5. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaip.2015.04.013>. Go to original source... Go to PubMed...
    4. Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci (Lond) 2017; 131(13): 1541-1558. Dostupné z DOI: <http://dx.doi.org/10.1042/CS20160487>. Go to original source... Go to PubMed...
    5. Berge M, Hacken NH, Cohen J et al. Small airway disease in asthma and COPD: clinical implications. Chest 2001; 139(2): 412-423. Dostupné z DOI: <http://dx.doi.org/10.1378/chest.10-1210>. Go to original source... Go to PubMed...
    6. Kašák V. Asthma bronchiale. 2. ed. Maxdorf: Praha 2013. ISBN 978-80-7345-325-1.
    7. Teřl M, Rybníček O. Asthma bronchiale v příčinách a klinických obrazech. 2. ed. GEUM: Cheb 2008. ISBN 978-80-86256-59-7.
    8. Nolte D. Asthma. Das Krankheitsbild. Der Asthmapatient. Die Therapie. 5th ed. Urban&Schwarzenberg: Munchen-Wien-Balatimore 1991: 81-84. ISBN 978-3541093540.
    9. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5): 1165-1185. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00128008>. Go to original source... Go to PubMed...
    10. Koblížek V, Chlumský J, Zindr V et al. Doporučený postup ČPFS pro diagnostiku a léčbu stabilní CHOPN. Aktualizace 2016. Dostupné z WWW: <http://www.pneumologie.cz/guidelines>.
    11. Padeletti M, Jelic S, LeJemtel TH. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 2008; 125(2):209-215. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2007.12.001>. Go to original source... Go to PubMed...
    12. Chlumský J, Fišerová J, Kociánová J et al. [Sekce patofyziologie dýchání]. Doporučený postup pro interpretaci základních vyšetření plicních funkcí. Aktualizace 2013. Dostupné z WWW: <(http://www.pneumologie.cz/guidelines/>.
    13. Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000; 161(1): 309-329. Go to original source... Go to PubMed...
    14. Dweik RA, Boggs PB, Erzurum SC et al. [American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications]. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184(5): 602-615. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.9120-11ST>. Go to original source... Go to PubMed...
    15. Gross NJ, Barnes PJ. New Terapies for Asthma and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2017; 195(2): 159-166. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201610-2074PP>. Go to original source... Go to PubMed...
    16. Terl M, Sedlak V, Cap P et al. Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy. Allergy 2017; 72(9): 1279-1287. Dostupné z DOI: <http://dx.doi.org/10.1111/all.13165>. Go to original source... Go to PubMed...
    17. Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun 2014; 48-49: 99-103. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaut.2014.01.018>. Erratum in J Autoimmun 2014; 55:94. Go to original source... Go to PubMed...
    18. Teřl M. Léčba astmatu - chyby a omyly každodenní praxe. Medicína pro praxi 2013; 10(3): 97-103.
    19. Kašák V. Inhalační systémy v terapii astmatu a chronické obstrukční plicní nemoci. Remedia 2014; 24(4): 315-320.
    20. Chung KF, Wenzel SE, Brozek JL et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43(2): 343-373. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00202013>. Erratum in Eur Respir J 2014; 43(4): 1216. Go to original source... Go to PubMed...
    21. Vogelmeier C, D'Urzo A, Pauwels R et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005; 26(5): 819-828.Erratum in Eur Respir J 2005; 26(6): 1191. Eur Respir J 2011; 38(2): 491. Go to original source... Go to PubMed...
    22. Stříž I. Biologická léčba astmatu. Acta Medicinae 2016; 5(10): 13-16.
    23. Sedlák V, Chlumský J, Teřl M et al. Doporučený postup diagnostiky a léčby obtížně léčitelného bronchiálního astmatu. Dostupné z WWW: <http://www.pneumologie.cz/guidelines/>.
    24. Normansell R, Walker S, Milan SJ et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev 2014; (1): CD003559. Dostupné z DOI: <http://dx.doi.org/10.1002/14651858.CD003559.pub4>. Go to original source... Go to PubMed...
    25. Krčmová I, Novosad J. Interleukin 5 a monoklonální anti-IL5 molekuly v léčbě bronchiálního astmatu. Postgraduální medicína 2017; 19(3): 249-255.
    26. Castro M, Zangrilli J, Wechsler ME et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 2015; 3(5): 355-366. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213-2600(15)00042-9>. Go to original source... Go to PubMed...
    27. Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Rep 2011; 11(5): 403-413. Dostupné z DOI: <http://dx.doi.org/10.1007/s11882-011-0217-4>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.